(Q33386308)

26 July 2017

title

Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange (English)

1 reference

26 July 2017

G A Kennedy

1

1 reference

26 July 2017

N Kearey

2

1 reference

26 July 2017

S Bleakley

3

1 reference

26 July 2017

J Butler

4

1 reference

26 July 2017

K Mudie

5

1 reference

26 July 2017

S Durrant

6

1 reference

26 July 2017

language of work or name

English

0 references

publication date

21 September 2009

1 reference

Bone Marrow Transplantation

26 July 2017

published in

1 reference

26 July 2017

volume

45

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

699-704

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2009.233

26 July 2017

exact match

0 references

cites work

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Transplantation-associated thrombotic microangiopathy: twenty-two years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Clinical significance of fragmented red cells after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Complete response in severe thrombotic microangiopathy post bone marrow transplantation (BMT-TM) after multiple plasmaphereses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

7 January 2021

Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

7 January 2021

Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

7 January 2021

Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

7 January 2021

Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

7 January 2021

Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.233

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.233

1 reference

Dimensions Publication ID

26 July 2017

1052165550

0 references

1 reference